Cardinal Health, Inc. (NYSE:CAH) Stock Position Trimmed by Russell Investments Group Ltd.

Russell Investments Group Ltd. cut its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 3.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 541,027 shares of the company's stock after selling 18,118 shares during the quarter. Russell Investments Group Ltd. owned about 0.22% of Cardinal Health worth $63,956,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of CAH. Benjamin Edwards Inc. grew its stake in Cardinal Health by 802.5% during the third quarter. Benjamin Edwards Inc. now owns 4,630 shares of the company's stock worth $512,000 after buying an additional 4,117 shares during the period. Hilltop Holdings Inc. purchased a new stake in Cardinal Health during the 3rd quarter worth $254,000. IHT Wealth Management LLC increased its holdings in Cardinal Health by 18.7% in the 3rd quarter. IHT Wealth Management LLC now owns 4,015 shares of the company's stock valued at $444,000 after purchasing an additional 632 shares in the last quarter. Royal London Asset Management Ltd. raised its position in Cardinal Health by 2.6% in the third quarter. Royal London Asset Management Ltd. now owns 100,257 shares of the company's stock valued at $11,030,000 after purchasing an additional 2,582 shares during the period. Finally, Quarry LP boosted its position in shares of Cardinal Health by 541.7% in the third quarter. Quarry LP now owns 616 shares of the company's stock worth $68,000 after buying an additional 520 shares during the period. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Price Performance

Shares of CAH stock traded up $2.77 on Friday, hitting $131.65. 2,168,139 shares of the stock traded hands, compared to its average volume of 2,179,592. The company's fifty day moving average is $129.33 and its 200 day moving average is $122.39. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $139.50. The company has a market capitalization of $31.80 billion, a PE ratio of 24.56, a PEG ratio of 1.49 and a beta of 0.61.

Remove Ads

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, equities research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a dividend yield of 1.54%. The ex-dividend date is Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is presently 37.69%.

Analyst Ratings Changes

CAH has been the topic of several analyst reports. JPMorgan Chase & Co. raised their target price on Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a report on Tuesday, February 4th. Wells Fargo & Company boosted their target price on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 4th. TD Cowen raised shares of Cardinal Health from a "hold" rating to a "buy" rating and raised their price target for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. Evercore ISI raised shares of Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price objective for the company in a research report on Tuesday, January 7th. Finally, Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and lifted their target price for the stock from $140.00 to $150.00 in a research report on Wednesday, February 5th. Four analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company's stock. According to data from MarketBeat, Cardinal Health currently has a consensus rating of "Moderate Buy" and an average target price of $140.86.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.